Hard to believe it’s already May. The activity at Kinetic River has been intense this winter and spring, with new product launches, articles in technical journals and trade magazines , and a variety of speaking engagements—not to mention expansion into new office and laboratory quarters…

Fluorescence Lifetime Flow Cytometer In cell biology and cancer research, there is often the need to measure cellular processes, protein function, protein-protein interactions, or molecular transport with subcellular resolution. Fluorescence lifetime is a powerful tool that can provide this information.…

  Dear Clients and Partners, As the year draws to a close, we’d like to take the opportunity to focus on some key recent developments. 2013 has been a year of partnerships: From our very productive continuing collaboration with Prof. Jessica Houston at…

It's been a busy summer. In several instances over the last couple of months I have been honored with invitations to participate and contribute to events relevant to the life sciences / biophotonics / medical device communities. Here are the…

CYTO 2013 (XXVIII Congress of the International Society for Advancement of Cytometry), the annual “watering-hole” gathering for cytometrists of all shapes and sizes, took place in San Diego this year, and it was exciting as ever. The scientific program turned up…

Recently I've had the chance to hear a thought-provoking lecture by Paul Yock, Professor of Medicine and Director of Biodesign at Stanford University, at the 10th anniversary of the founding of the Bio2Device Group. Dr. Yock spoke about the global evolution…

Time-resolved flow cytometry enables cell biologists to study proteins and cellular microenvironment San Francisco, Calif., USA, February 3, 2013 – Kinetic River Corp., a leader in flow cytometry instrumentation design and product development, officially launched the Danube today at Photonics West’s BiOS Expo…

Personalized medicine seems all the buzz these days. People talk about things like whole-genome analysis to determine individual propensity towards specific disease states, or the development of drugs tailored to be maximally effective, and minimally side-effective, for certain narrowly defined…